TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Technology-Assisted Case Management in Low Income Adults With Type 2 Diabetes
Brief Summary: The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQHC) in coastal South Carolina.


Options:
A: Arm Label: Home Monitoring; Type: ACTIVE_COMPARATOR; Interventions: Other: Home Monitoring | Arm Label: In-Office Conventional Follow-up; Type: OTHER; Interventions: Other: In-Office Conventional Follow-up | Intervention Type: OTHER; Name: Home Monitoring; Assigned to Arm(s): Home Monitoring | Intervention Type: OTHER; Name: In-Office Conventional Follow-up; Assigned to Arm(s): In-Office Conventional Follow-up
B: Arm Label: Remote Arm; Type: N/A; Interventions: Device: The Medtronic CareLink system (Minneapolis, MN, USA). | Arm Label: Implantable defibrillator patients; Type: N/A; Interventions: Device: The Medtronic CareLink system (Minneapolis, MN, USA). | Intervention Type: DEVICE; Name: The Medtronic CareLink system (Minneapolis, MN, USA).; Assigned to Arm(s): Implantable defibrillator patients, Remote Arm
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Technology Assisted Case Management; Type: EXPERIMENTAL; Interventions: Behavioral: Technology-Assisted Case Management | Intervention Type: BEHAVIORAL; Name: Technology-Assisted Case Management; Assigned to Arm(s): Technology Assisted Case Management
D: Arm Label: remote monitoring; Type: EXPERIMENTAL; Interventions: Device: heart failure remote patient monitoring system | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: heart failure remote patient monitoring system; Assigned to Arm(s): remote monitoring

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer in the County of Valles Occidental: CRICERVA Clinical Trial.
Brief Summary: The aim of this study was to compare the effectiveness and the costs of three types of population interventions to increase the number of female participants in the screening programmes for cancer of the cervix carried out by Primary Care in four Basic Health Care Areas.


Options:
A: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit mailed directly | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit on demand | Arm Label: Intervention group 3; Type: EXPERIMENTAL; Interventions: Behavioral: Second reminder | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit mailed directly; Assigned to Arm(s): Intervention group 1 | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit on demand; Assigned to Arm(s): Intervention group 2 | Intervention Type: BEHAVIORAL; Name: Second reminder; Assigned to Arm(s): Intervention group 3
B: Arm Label: control 1; Type: N/A; Interventions: N/A | Arm Label: Intervention 1; Type: N/A; Interventions: N/A | Arm Label: intervention 2; Type: N/A; Interventions: N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Preventive Health Record (IPHR) | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: "Standard" preventive care | Intervention Type: BEHAVIORAL; Name: Interactive Preventive Health Record (IPHR); Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: "Standard" preventive care; Assigned to Arm(s): Control
D: Arm Label: invitation letter; Type: EXPERIMENTAL; Interventions: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer | Arm Label: Invitation letter, informative leaflet and phone call reminder; Type: EXPERIMENTAL; Interventions: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer | Arm Label: Invitation letter and informative leaflet; Type: EXPERIMENTAL; Interventions: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer | Intervention Type: OTHER; Name: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer; Assigned to Arm(s): Invitation letter and informative leaflet, Invitation letter, informative leaflet and phone call reminder, invitation letter

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Maximum Alveolar Recruitment Maneuver Plus Titrated PEEP Versus ARDSNet Strategy for ARDS
Brief Summary: Acute respiratory distress syndrome (ARDS) is a common scenario in intensive care unit. Discussions about it is exponentially growing up due its high mortality rates all over the world and low quality of life among survivors. Mechanical ventilation is recognized to play an important role in treatment of patients with ARDS. However, mechanical ventilation itself has the potential to produce or worsen alveolar injury if inadequate strategies are chosen. Several studies compared different mechanical ventilation strategies in ARDS but the results remain uncertain regarding their influence on survival in patients with ARDS. Thus, this is a multicentric randomized controlled trial, with allocation concealment and intention to treat analysis to investigate if maximum alveolar recruitment maneuver in association to Positive end-expiratory pressure (PEEP) titrated by static compliance of respiratory system (ART strategy) is able to increase 28 days survival in patients with moderate to severe ARDS compared to conventional strategy proposed by the ARDS Clinical Network (ARDSNet strategy). Patients considered to this trial are those in mechanical ventilation with diagnosis of moderate to severe ARDS less than 72hours. Patients included will be randomized to receive ART strategy or ARDSNet strategy and will be followed until hospital discharge, 28 days and 6 months.


Options:
A: Arm Label: PHARLAP ventilation group; Type: EXPERIMENTAL; Interventions: Other: PHARLAP mechanical ventilation strategy | Arm Label: Control group ventilation; Type: ACTIVE_COMPARATOR; Interventions: Other: Control group mechanical ventilation strategy | Intervention Type: OTHER; Name: PHARLAP mechanical ventilation strategy; Assigned to Arm(s): PHARLAP ventilation group | Intervention Type: OTHER; Name: Control group mechanical ventilation strategy; Assigned to Arm(s): Control group ventilation
B: Arm Label: Focal ARDS; Type: EXPERIMENTAL; Interventions: Procedure: Mechanical ventilation | Arm Label: non focal ARDS; Type: OTHER; Interventions: Procedure: Mechanical ventilation | Intervention Type: PROCEDURE; Name: Mechanical ventilation; Assigned to Arm(s): Focal ARDS, non focal ARDS
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: prone position | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: prone position; Assigned to Arm(s): A
D: Arm Label: ART Strategy; Type: EXPERIMENTAL; Interventions: Other: ART Strategy | Arm Label: ARDSNet Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: ARDSNet Strategy | Intervention Type: OTHER; Name: ART Strategy; Assigned to Arm(s): ART Strategy | Intervention Type: OTHER; Name: ARDSNet Strategy; Assigned to Arm(s): ARDSNet Strategy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of an One-year Physical Exercise Intervention on Prognosis, Side-effects and Complications After Allogeneic Stem Cell Transplantation
Brief Summary: The PETRA-Study is a randomized, controlled trial and designed to examine the effects of an one-year physical exercise intervention on prognosis, side-effects and complications after allogeneic stem cell transplantation.

The exercise intervention includes both, resistance and endurance training. Patients assigned to the control group perform a relaxation program (progressive muscle relaxation - Jacobsen) and have the same frequency of social contact.


Options:
A: Arm Label: resistance and endurance exercise; Type: EXPERIMENTAL; Interventions: Behavioral: exercise and relaxation | Arm Label: relaxation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise and relaxation | Intervention Type: BEHAVIORAL; Name: exercise and relaxation; Assigned to Arm(s): relaxation, resistance and endurance exercise
B: Arm Label: Fatigued patients: Immediate start CBT; Type: OTHER; Interventions: Behavioral: immediate CBT | Arm Label: fatigues patients: delayed CBT (after 6 months); Type: OTHER; Interventions: Behavioral: Delayed CBT | Arm Label: non-fatiqued controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: immediate CBT; Assigned to Arm(s): Fatigued patients: Immediate start CBT | Intervention Type: BEHAVIORAL; Name: Delayed CBT; Assigned to Arm(s): fatigues patients: delayed CBT (after 6 months)
C: Arm Label: Exercise based multimodal intervention; Type: EXPERIMENTAL; Interventions: Other: Exercise based multimodal intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise based multimodal intervention; Assigned to Arm(s): Exercise based multimodal intervention
D: Arm Label: Telephone Counselling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone counselling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telephone counselling; Assigned to Arm(s): Telephone Counselling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Relapse Following Involuntary Smoking Abstinence
Brief Summary: The prevalence of tobacco use in the military is too high. This study is designed to take advantage of the 8.5 weeks of forced tobacco cessation during Basic Military Training and develop effective interventions to prevent tobacco relapse.

Hypotheses or Research Questions:

* Are there differences in the rate of relapse between three groups participating in a tobacco abstinence maintenance intervention?
* Do the tobacco abstinence maintenance interventions delay relapse?


Options:
A: Intervention Type: BEHAVIORAL; Name: Smoking Relapse Prevention; Assigned to Arm(s): N/A
B: Arm Label: Randomized Phase: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Randomized Phase: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Randomized Phase: Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Randomized Phase: Placebo
C: Arm Label: Ban & Informational Pamphlet; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Informational Pamphlet | Arm Label: Ban & Tailored Pamphlet; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Tailored Pamphlet | Arm Label: Ban & Tailored Pamphlet & Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Tailored Pamphlet, Behavioral: Relapse Prevention Intervention | Intervention Type: BEHAVIORAL; Name: Tobacco Use Ban; Assigned to Arm(s): Ban & Informational Pamphlet, Ban & Tailored Pamphlet, Ban & Tailored Pamphlet & Intervention | Intervention Type: BEHAVIORAL; Name: Tailored Pamphlet; Assigned to Arm(s): Ban & Tailored Pamphlet, Ban & Tailored Pamphlet & Intervention | Intervention Type: BEHAVIORAL; Name: Informational Pamphlet; Assigned to Arm(s): Ban & Informational Pamphlet | Intervention Type: BEHAVIORAL; Name: Relapse Prevention Intervention; Assigned to Arm(s): Ban & Tailored Pamphlet & Intervention
D: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Relapse Following Involuntary Smoking Abstinence
Brief Summary: The prevalence of tobacco use in the military is too high. This study is designed to take advantage of the 8.5 weeks of forced tobacco cessation during Basic Military Training and develop effective interventions to prevent tobacco relapse.

Hypotheses or Research Questions:

* Are there differences in the rate of relapse between three groups participating in a tobacco abstinence maintenance intervention?
* Do the tobacco abstinence maintenance interventions delay relapse?


Options:
A: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling (Quitline), Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) | Arm Label: Financial Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: Smoking cessation counseling (Quitline), Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy), Behavioral: Financial incentives | Intervention Type: BEHAVIORAL; Name: Smoking cessation counseling (Quitline); Assigned to Arm(s): Financial Incentives, Usual care | Intervention Type: BEHAVIORAL; Name: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy); Assigned to Arm(s): Financial Incentives, Usual care | Intervention Type: BEHAVIORAL; Name: Financial incentives; Assigned to Arm(s): Financial Incentives
B: Arm Label: Ban & Informational Pamphlet; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Informational Pamphlet | Arm Label: Ban & Tailored Pamphlet; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Tailored Pamphlet | Arm Label: Ban & Tailored Pamphlet & Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Use Ban, Behavioral: Tailored Pamphlet, Behavioral: Relapse Prevention Intervention | Intervention Type: BEHAVIORAL; Name: Tobacco Use Ban; Assigned to Arm(s): Ban & Informational Pamphlet, Ban & Tailored Pamphlet, Ban & Tailored Pamphlet & Intervention | Intervention Type: BEHAVIORAL; Name: Tailored Pamphlet; Assigned to Arm(s): Ban & Tailored Pamphlet, Ban & Tailored Pamphlet & Intervention | Intervention Type: BEHAVIORAL; Name: Informational Pamphlet; Assigned to Arm(s): Ban & Informational Pamphlet | Intervention Type: BEHAVIORAL; Name: Relapse Prevention Intervention; Assigned to Arm(s): Ban & Tailored Pamphlet & Intervention
C: Arm Label: Longitudinal Care; Type: EXPERIMENTAL; Interventions: Behavioral: smoking cessation | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: smoking cessation | Intervention Type: BEHAVIORAL; Name: smoking cessation; Assigned to Arm(s): Longitudinal Care, Usual Care
D: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of an Intrahospital Exercise Program in Functional Capacity of Old Inpatients
Brief Summary: Background The Activity in GEriatric acute CARe (AGECAR) is a randomized control trial to assess the effectiveness of an intrahospital strength and walk program during short hospital stays for improving functional capacity of patients aged 75 years or older.


Options:
A: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Other: Experimental group | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Control group | Intervention Type: OTHER; Name: Experimental group; Assigned to Arm(s): Experimental group | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: Strength training; Type: EXPERIMENTAL; Interventions: Other: Strength training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Strength training; Assigned to Arm(s): Strength training
C: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: High-protein diet and resistance training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: High-protein diet and resistance training; Assigned to Arm(s): Intervention
D: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partial Oral Treatment of Endocarditis
Brief Summary: Background Current management of infective endocarditis include admission and treatment with parenteral antibiotics for 4 weeks - 6 weeks. Resource demands and psychological issues of present management strategy make it highly relevant to seek for alternative more lenient alternatives. Experiences with oral treatment are only sporadically described, but observational data suggest that oral treatment could be a feasible option. The investigators have in 2010 treated 12 endocarditis patients with partial oral antibiotics with a 100% success rate.

Study design The POET study is a Danish multicenter, prospective, randomized, open label study. The primary aim is to show non-inferiority of partial oral treatment with antibiotics of endocarditis compared to full parenteral treatment. Stable patients (n=400) with streptococci, staphylococci or enterococci infecting the mitral valve or the aortic valve will be included. After a minimum of 10 days of parenteral treatment, patients will be randomized to oral therapy or parenteral therapy. Special recommendations for oral treatment have been developed based on expected minimal inhibitory concentrations and pharmacokinetic calculations. Patients will be followed for 6 months after completion of antibiotic therapy. The primary endpoint is a composition of all cause mortality, unplanned cardiac surgery, embolic events and relapse of positive blood cultures with the primary pathogen.


Options:
A: Arm Label: Guideline treatment with parenteral antibiotics; Type: ACTIVE_COMPARATOR; Interventions: Drug: Guideline treatment with parenteral antibiotics | Arm Label: Oral treatment with antibiotics; Type: EXPERIMENTAL; Interventions: Drug: Oral treatment with antibiotics for endocarditis | Intervention Type: DRUG; Name: Oral treatment with antibiotics for endocarditis; Assigned to Arm(s): Oral treatment with antibiotics | Intervention Type: DRUG; Name: Guideline treatment with parenteral antibiotics; Assigned to Arm(s): Guideline treatment with parenteral antibiotics
B: Arm Label: TAVI cohort; Type: N/A; Interventions: Procedure: Aortic valve replacement | Arm Label: SAVR cohort; Type: N/A; Interventions: Procedure: Aortic valve replacement | Intervention Type: PROCEDURE; Name: Aortic valve replacement; Assigned to Arm(s): SAVR cohort, TAVI cohort
C: Intervention Type: DRUG; Name: daptomycin; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Fosfomycin and imipenem | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Intervention Type: DRUG; Name: Fosfomycin and imipenem; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Bifidobacterium Bifidum Supplementation on Morbidity of Very Low Birth Weight Infants
Brief Summary: Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm infants who received Bifidobacterium bifidum early after birth. In order to evaluate these beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to preterm infants improve enteral feeding and growth in very low birth weight infants.


Options:
A: Arm Label: probiotic group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri; Assigned to Arm(s): probiotic group | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: VSL#3 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: VSL#3; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Saccharomyces boulardii; Type: EXPERIMENTAL; Interventions: Drug: Saccharomyces boulardii | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Saccharomyces boulardii; Assigned to Arm(s): Saccharomyces boulardii | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): control
D: Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Bifidobacterium bifidum supplementation | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo contains dextrin | Intervention Type: DIETARY_SUPPLEMENT; Name: Bifidobacterium bifidum supplementation; Assigned to Arm(s): Active | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo contains dextrin; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Bifidobacterium Bifidum Supplementation on Morbidity of Very Low Birth Weight Infants
Brief Summary: Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm infants who received Bifidobacterium bifidum early after birth. In order to evaluate these beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to preterm infants improve enteral feeding and growth in very low birth weight infants.


Options:
A: Arm Label: "Milk" containing B. Lactis; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic supplementation | Arm Label: "Milk" containing placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Milk containing placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic supplementation; Assigned to Arm(s): "Milk" containing B. Lactis | Intervention Type: DIETARY_SUPPLEMENT; Name: Milk containing placebo; Assigned to Arm(s): "Milk" containing placebo
B: Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Bifidobacterium bifidum supplementation | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo contains dextrin | Intervention Type: DIETARY_SUPPLEMENT; Name: Bifidobacterium bifidum supplementation; Assigned to Arm(s): Active | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo contains dextrin; Assigned to Arm(s): Placebo
C: Arm Label: Saccharomyces boulardii; Type: EXPERIMENTAL; Interventions: Drug: Saccharomyces boulardii | Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Saccharomyces boulardii; Assigned to Arm(s): Saccharomyces boulardii | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): control
D: Arm Label: Main Study; Type: N/A; Interventions: N/A | Arm Label: Gestational Diabetes Mellitus Cohort; Type: N/A; Interventions: N/A | Arm Label: Fresh Milk Cohort; Type: N/A; Interventions: N/A | Arm Label: RNA Milk Fat Cohort; Type: N/A; Interventions: N/A | Arm Label: Skin Study; Type: N/A; Interventions: N/A | Arm Label: BMMI Project; Type: N/A; Interventions: N/A

Answer: B